Rhinomed Limited
OTC: RHNMF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael Johnson
- Headquarters
- Cremorne, Australia
- IPO year
- 2017
- Market cap
- $5.4M
- Website
- https://www.rhinomed.global
Loading RHNMF…
Loading profile data…Frequently asked questions about RHNMF
What does Rhinomed Limited (RHNMF) do?
Headquartered in Cremorne, Australia, Rhinomed Limited, founded in 2004, is a global innovator specializing in the research, development, and commercialization of consumer and medical devices. The company's core expertise lies in wearable nasal technologies engineered to improve breathing, enhance sleep quality, promote general health, and aid i...
Where does RHNMF trade?
Rhinomed Limited (RHNMF) trades on the Other OTC.
What sector is RHNMF in?
Rhinomed Limited (RHNMF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Rhinomed Limited?
Michael Johnson is the chief executive officer of Rhinomed Limited (RHNMF).
Where is Rhinomed Limited headquartered?
Rhinomed Limited is headquartered in Australia.
Does RHNMF pay a dividend?
Rhinomed Limited (RHNMF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RHNMF go public?
Rhinomed Limited (RHNMF) completed its initial public offering in 2017.